Vitapure Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 2.81 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.02 Cr
as on 15-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 34.22 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Profit 42.58%
(FY 2023)
- Ebitda 43.28%
(FY 2023)
- Net Worth -0.87%
(FY 2023)
- Total Assets -0.00%
(FY 2023)
About Vitapure Pharmacare
The Corporate was formerly known as Amritdayini Cancer Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.81 Cr and a paid-up capital of Rs 1.02 Cr.
The company currently has active open charges totaling ₹34.22 Cr.
Anjul Agarwal and Anuradha Agarwal serve as directors at the Company.
- CIN/LLPIN
U70102UP2011PTC043804
- Company No.
043804
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vitapure Pharmacare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjul Agarwal  | Director | 22-Jun-2022 | Current |
| Anuradha Agarwal | Director | 22-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Vitapure Pharmacare.
Vitapure Pharmacare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 42.58% increase in profit. The company's net worth dipped by a decrease of 0.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitapure Pharmacare?
In 2023, Vitapure Pharmacare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Radhashok Pharmachem Private LimitedActive 8 years 7 months
Anjul Agarwal and Anuradha Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 May 2024 | ₹20.00 Cr | Open |
Others Creation Date: 19 Mar 2024 | ₹5.00 Cr | Open |
Axis Bank Limited Creation Date: 31 Mar 2022 | ₹9.22 Cr | Open |
How Many Employees Work at Vitapure Pharmacare?
Unlock and access historical data on people associated with Vitapure Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitapure Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitapure Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
